MedPath

Actinium

Generic Name
Actinium
Drug Type
Small Molecule
Chemical Formula
Ac
CAS Number
7440-34-8
Unique Ingredient Identifier
NIK1K0956U

Overview

Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/03/01
Phase 1
Recruiting
City of Hope Medical Center
2022/05/05
Phase 1
Recruiting
City of Hope Medical Center
2022/01/24
Phase 1
Recruiting
City of Hope Medical Center
2019/01/11
Phase 1
Completed
2016/06/03
Phase 2
Completed
2014/06/24
Phase 1
Completed
2008/01/11
Phase 2
Completed
2007/01/18
Phase 2
Completed
2005/09/19
Phase 3
Completed
2003/10/07
Phase 3
Active, not recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.